#fda-regulatory-process

[ follow ]
Silicon Valley
fromSFGATE
1 day ago

Calif. biotech company lays off almost half of staff after 78% stock drop

Gossamer Bio laid off 48% of its workforce after its blood pressure drug study missed primary endpoints, causing a 78% stock price decline.
[ Load more ]